Baxano Surgical Company Profile (NASDAQ:BAXS)

Analyst Ratings

Consensus Ratings for Baxano Surgical (NASDAQ:BAXS) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Baxano Surgical (NASDAQ:BAXS)
Show:
DateFirmActionRatingPrice TargetActions
11/13/2014Summer StreetDowngradeBuy -> SellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for Baxano Surgical (NASDAQ:BAXS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/5/2014($0.14)($0.18)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014($0.12)($0.19)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2014($0.14)($0.19)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2013Q2 2013($0.14)($0.21)$6.90 million$3.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Baxano Surgical (NASDAQ:BAXS)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Baxano Surgical (NASDAQ:BAXS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Baxano Surgical (NASDAQ:BAXS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
8/15/2014Kenneth Michael RealiCEOBuy10,000$0.38$3,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2014Kenneth Michael RealiCEOBuy7,050$0.71$5,005.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/5/2013Kenneth Michael RealiCEOBuy10,500$1.11$11,655.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/31/2013Roderick A YoungDirectorBuy1,340,034$2.28$3,055,277.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Headlines for Baxano Surgical (NASDAQ:BAXS)
No headlines for this company have been tracked by MarketBeat.com

Social

About Baxano Surgical

Baxano Surgical, Inc., formerly Baxano Inc. is a medical device company. The Company is focused on designing, developing and marketing minimally invasive products to treat degenerative conditions of the spine affecting the lumbar region. The Company markets the AxiaLIF pre-sacral access and interbody fusion system for single and two level lower lumbar fusion, the VEO lateral access and interbody fusion system, the iO-Flex set of flexible instruments used by surgeons during spinal decompression procedures, and the iO-Tome instrument for rapid and precise removal of bone, specifically the facet joints, a technique which is commonly performed in spinal fusion procedures. The Company's other products include: Vectre facet screw system, Bi-Ostetic bone void filler, bowel retractors, discectomy tools, and a bone graft harvesting system that can be used to extract bone graft from the patient's hip for use in fusion procedures.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BAXS
  • CUSIP:
Key Metrics:
  • Previous Close: $0.00
  • 50 Day Moving Average: $N/A
  • 200 Day Moving Average: $N/A
  • P/E Ratio: N/A
  • P/E Growth: N/A
  • Market Cap: $N/A
  • Current Year EPS Consensus Estimate: $-0.5700 EPS
  • Next Year EPS Consensus Estimate: $-0.4000 EPS
Additional Links:
Baxano Surgical (NASDAQ:BAXS) Chart for Monday, July, 25, 2016